Archeon Medical Company Profile

Background

Founded in 2018 by Alban De Luca and Pierre-Edouard Saillard, Archeon Medical is a French healthcare technology company headquartered in Besançon, France. The company specializes in developing advanced technologies to enhance manual ventilation practices, particularly in emergency medical situations. Archeon's mission is to simplify care and assist first aid teams in delivering optimal ventilation to patients during life-threatening emergencies. Their flagship product, EOlife, has been instrumental in revolutionizing manual ventilation by providing real-time feedback on tidal volume and ventilation frequency, thereby improving patient outcomes.

Key Strategic Focus

Archeon Medical's strategic focus centers on innovating manual ventilation solutions to improve emergency care. The company specializes in developing devices that offer real-time feedback to healthcare professionals, ensuring adherence to ventilation guidelines and enhancing patient safety. Their primary market includes emergency medical services (EMS), hospitals, and training institutions across Europe, the Middle East, Asia-Pacific, and North America.

Financials and Funding

In July 2024, Archeon Medical secured a multi-million-euro funding round led by Bpifrance, BNP Paribas, and Caisse d'Epargne. This investment aims to accelerate the company's international expansion and support the development of new ventilation technologies. The funding is part of the France 2030 program, reflecting confidence in Archeon's innovation and long-term vision.

Pipeline Development

Archeon's flagship product, EOlife, is a ventilation feedback device designed to enhance the quality of manual ventilations during cardiopulmonary resuscitation (CPR). EOlife provides real-time measurements of delivered tidal volume, addressing critical challenges such as hypo- and hyperventilation. The device received FDA approval in 2023 and has been adopted by major healthcare institutions, including Johns Hopkins EMS Services, Palo Alto Fire Department, Stanford’s Children Hospital, and Rush University Hospital.

Technological Platform and Innovation

Archeon Medical's innovation is exemplified by EOlife, the first smart system that assists manual pulmonary ventilation for patients in cardiopulmonary arrest. EOlife measures ventilation quality via a sensor fitted to the oxygen mask, calculating the quantities of oxygen delivered and exhaled. The device's software interprets these measurements to determine the patient's lung profile, adjusting the oxygen delivery in real time. This technology addresses the critical issue of ineffective manual ventilation, which can significantly increase the risk of patient mortality.

Leadership Team

Alban De Luca: Co-founder and Chief Executive Officer. Under his leadership, Archeon has secured significant funding and expanded its global presence.

Pierre-Edouard Saillard: Co-founder. He has been instrumental in developing Archeon's innovative technologies.

Valentine Oqda: Head of U.S. Operations. She oversees the company's expansion and operations in the United States.

Leadership Changes

In December 2024, Archeon Medical announced the establishment of a U.S. subsidiary, appointing Valentine Oqda as Head of U.S. Operations. This strategic move aims to strengthen the company's presence in the North American market.

Competitor Profile

Market Insights and Dynamics

The global manual ventilation market is experiencing growth due to increasing awareness of the importance of effective ventilation during emergency care. Innovations like EOlife are setting new standards, emphasizing the need for real-time feedback and adherence to ventilation guidelines.

Competitor Analysis

Key competitors in the manual ventilation market include:

Ambu: A leader in healthcare solutions, known for the Ambu® Bag™, the first self-inflating resuscitator introduced in 1956. Ambu has a longstanding reputation in manual ventilation devices.

Laerdal Medical: Specializes in medical training and emergency care products, including ventilation devices.

Philips Healthcare: Offers a range of medical devices, including ventilators and patient monitoring systems.

Archeon's EOlife differentiates itself by providing real-time feedback on ventilation parameters, a feature not commonly found in competitors' products.

Strategic Collaborations and Partnerships

Archeon Medical has established several strategic partnerships to enhance its market presence:

Ambu: In February 2025, Archeon partnered with Ambu for the distribution of EOlife and EOlifeX devices in the U.S. market. This collaboration aims to reshape manual ventilation practices and improve patient safety.

WorldPoint: In September 2024, Archeon collaborated with WorldPoint for the distribution of EOlifeX, expanding access to high-performance manual ventilation training technology across the United States.

AED Professionals: In July 2024, Archeon partnered with AED Professionals to distribute EOlife and EOlifeX devices, further expanding its reach in the U.S. market.

Operational Insights

Archeon's strategic partnerships and technological innovations position the company as a leader in manual ventilation solutions. The establishment of a U.S. subsidiary and collaborations with key industry players like Ambu and WorldPoint enhance its competitive advantage and market reach.